Test a treatment for erectile problems and early ejaculation
Treatments studied
Part of Kidney & urinary, Mental health clinical trials.
This Phase 3 study tests how well a Toronto Association treatment works for men who have both erectile dysfunction and premature ejaculation, while also checking safety. You may be able to join if your symptoms match the study targets and you can stay on a steady, stable sexual routine and relationship during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can read, understand, and sign the consent form and agree to follow study rules
- You are a man age 18 or older
- You are in a stable, monogamous relationship for at least 6 months, and you plan to keep it during the study
- You have erectile dysfunction and are already using a PDE-5 inhibitor (a common erection medicine) that is working
- You have premature ejaculation (your timing is very short, at or under 2 minutes) and your questionnaire score is high enough to qualify
- You and/or your partner use at least one contraception method
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a painless electrical nerve stimulation (TENS) treatment can help men with premature ejaculation last longer and feel more in control. It's for men who have had this condition for at least 6 months and are in a stable relationship.
This Phase 1 study tests how different tadalafil gummy-style products move through your body after a single dose. It’s done in healthy adult volunteers and helps scientists understand dosing and absorption safely.
This trial tests if pelvic floor therapy (exercises) can help men with erectile dysfunction or premature ejaculation. It may be a drug-free option to improve your sexual health.
This study tests whether taking tadalafil daily, either alone or with a second treatment, works better for men with erectile dysfunction who have not responded to on-demand pills. It aims to help men who have not had success with current treatments.
This trial studies whether daily tadalafil (5 mg) can improve early urinary trouble and erection function after endoscopic prostate tissue removal. It may help men whose urinary symptoms continued even after prior medicine.
This trial tests a new drug, DTT106, for men who have both erectile dysfunction and an enlarged prostate (BPH). It is for men already taking dutasteride and tamsulosin and aims to see if the new treatment improves erections better.
Hear when a new Erectile Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.